Dr. Sally Yunsun Kim is a recipient of the Wellcome Trust Institutional Strategic Support Fund Springboard Fellowship. Dr. Kim joined the Dean Lab at the National Heart and Lung Institute (NHLI) in 2018 upon the award of the European Respiratory Society (ERS) / European Molecular Biology Society (EMBO) Long Term Research Fellowship.
Her current research interest is aimed at developing extracellular vesicles as a tool to study altered biology of lung tissue. During her ERS/EMBO fellowship, she developed an innovative approach to study lung injury and repair. Dr Kim also developed a semi high-throughput method using state-of-the-art precision cut lung slices for identifying optimal pro-repair molecules to enhance the Wnt-stimulated Planar Cell Polarity pathway, an important signalling pathway in promoting lung repair following injury. More information on this is available on our research group website: www.lungdevelopmentandrepair.org
Prior to joining the NHLI, Dr. Kim completed her PhD at The University of Sydney, where she was awarded the John C Harsanyi Graduate Medal for Innovation in 2019. Her PhD was focused on developing a formulation for direct aerosol delivery of stem cells and extracellular vesicles for lung tissue repair.
et al., 2022, Made by cells for cells - extracellular vesicles as next-generation mainstream medicines, Journal of Cell Science, Vol:135, ISSN:0021-9533
et al., 2021, The Acid Injury and Repair (AIR) model: A new ex vivo tool to understand lung repair, Biomaterials, Vol:267, ISSN:0142-9612
et al., 2020, An ex vivo acid injury and repair (AIR) model using precision-cut lung slices to understand lung injury and repair, Current Protocols in Mouse Biology, Vol:10, ISSN:2161-2617, Pages:e85-e85
et al., 2020, The planar polarity component Vangl2 is a key regulator of mechanosignaling, Frontiers in Cell and Developmental Biology, Vol:8, ISSN:2296-634X
Chrzanowski W, Kim SY, McClements L, 2020, Can Stem Cells Beat COVID-19: Advancing Stem Cells and Extracellular Vesicles Toward Mainstream Medicine for Lung Injuries Associated With SARS-CoV-2 Infections, Frontiers in Bioengineering and Biotechnology, Vol:8, ISSN:2296-4185